13 March 2023

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

13 March 2023 | n=25

  1. Parczewski M, Jablonowska E, Wojcik-Cichy K, Zhyvytsia D, et al.
    Clinical perspective on HIV care of Ukrainian war refugees in Poland.
    Clin Infect Dis 2023.

  2. Boulware DR, Jarvis JN.
    Timing of antiretroviral therapy in cryptococcal meningitis: What we can (and cannot) learn from observational data.
    Clin Infect Dis 2023.

  3. Ron R, Moreno E, Martinez-Sanz J, Branas F, et al.
    CD4/CD8 ratio during HIV treatment: time for routine monitoring?
    Clin Infect Dis 2023.

  4. Ingle SM, Miro JM, May MT, Cain LE, et al.
    Early antiretroviral therapy not associated with higher cryptococcal meningitis mortality in people with HIV in high-income countries: an international collaborative cohort study.
    Clin Infect Dis 2023.

  5. Bonnet M, Gabillard D, Domoua S, Muzoora C, et al.
    High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF(R) for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV.
    Clin Infect Dis 2023.

  6. Pandey K, Fairley CK, Chen MY, Williamson DA, et al.
    Changes in the syphilis reactive plasma regain (RPR) titre between diagnosis and treatment.
    Clin Infect Dis 2022.

  7. Clarke KEN, Hong K, Schoonveld M, Greenspan AI, et al.
    Severity of COVID-19 Hospitalization Outcomes and Patient Disposition Differ by Disability Status and Disability Type.
    Clin Infect Dis 2022.

  8. Harris E.
    Severe Form of Mpox Identified in Patients With Advanced HIV.
    JAMA 2023.

  9. Ssempijja V, Ssekubugu R, Kigozi G, Nakigozi G, et al.
    J Acquir Immune Defic Syndr 2023.

  10. Qian Y, Wang L, Xing Y, Yin L, et al.
    Tenofovir concentration is not enough in intraocular tissues of patients with HIV-infection.
    J Acquir Immune Defic Syndr 2023.

  11. Okegbe T, Amzel A, Gunnala R, Abuelgasim K, et al.
    A Landscape Analysis of Prevention of Vertical Transmission Program Data and Interventions from Fiscal Years 2019 to 2021.
    J Acquir Immune Defic Syndr 2023.

  12. Weimann L, Schafer G, Matthews H, Maria F, et al.
    Prospective single center cohort study on HIV pre-exposure prophylaxis reveals transient but relevant elevations in transaminase levels in some participants albeit otherwise high tolerability.
    J Acquir Immune Defic Syndr 2023.

  13. Hamill MM, Hu F, Adebajo S, Kokogho A, et al.
    Food and water insecurity in sexual and gender minority groups living with HIV in Lagos, Nigeria.
    J Acquir Immune Defic Syndr 2023.

  14. Satanon S, Kiertiburanakul S, Boonnak K, Bruminhent J, et al.
    A Prospective Immunogenicity Study of a Quadrivalent Inactivated Influenza Vaccine among persons with HIV with Different Levels of CD4 Cell Count.
    J Acquir Immune Defic Syndr 2023.

  15. Poteat TC, Wirtz AL, Adams D, Linton SL, et al.
    Interruptions in HIV Prevention and Treatment Due to the COVID-19 Pandemic: A Cross-sectional Study of Transgender and Gender Nonbinary Adults in the U.S.
    J Acquir Immune Defic Syndr 2023.

  16. Yu X, Kuo YF, Raji MA, Berenson AB, et al.
    Dementias among older males and females in the U.S. Medicare system with and without HIV.
    J Acquir Immune Defic Syndr 2023.

  17. Mishra A, Mshweshwe-Pakela N, Kubeka G, Hansoti B, et al.
    Systems Analysis to Increase HIV Testing Delivery and HIV Diagnosis in Primary Care Clinics in South Africa.
    J Acquir Immune Defic Syndr 2021;87:1048-1054.

  18. Bavinton BR, Vaccher S, Jin F, Prestage GP, et al.
    High Levels of Prevention-Effective Adherence to HIV PrEP: An Analysis of Substudy Data From the EPIC-NSW Trial.
    J Acquir Immune Defic Syndr 2021;87:1040-1047.

  19. Cornelisse VJ, Traeger MW, Wright EJ, Murphy D, et al.
    Brief Report: Low Incidence of Hepatitis C Among a Cohort of HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP) in Melbourne, Australia, and the Contribution of Sexual Transmission.
    J Acquir Immune Defic Syndr 2021;87:1011-1015.

  20. Okere NE, Lennox L, Urlings L, Ford N, et al.
    Exploring Sustainability in the Era of Differentiated HIV Service Delivery in Sub-Saharan Africa: A Systematic Review.
    J Acquir Immune Defic Syndr 2021;87:1055-1071.

  21. Hastie E, Moser C, Sun X, Lennox J, et al.
    Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding during Suppressive Antiretroviral Therapy.
    J Infect Dis 2023.

  22. Saghazadeh A, Rezaei N.
    Inborn Errors of Immunity and Worries During the Monkeypox Outbreak.
    J Med Virol 2023.

  23. Corma-Gomez A, Fernandez-Fuertes M, Vinuela L, Dominguez C, et al.
    Reduced neutralizing antibody response to SARS-CoV-2 vaccine booster dose in people living with HIV with severe immunosuppression.
    J Med Virol 2023.

  24. Esmail A, Randall P, Oelofse S, Tomasicchio M, et al.
    Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial.
    Nat Med 2023.

  25. .
    The Fauci Phenomenon.
    N Engl J Med 2023;388:e28.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

27 March 2023

20 March 2023

13 March 2023

06 March 2023

27 February 2023

13 March 2023

Multidisciplinary Journal Club

  1. Heyland DK, Patel J, Compher C, Rice TW, et al.
    The effect of higher protein dosing in critically ill patients with high nutritional risk (EFFORT Protein): an international, multicentre, pragmatic, registry-based randomised trial.
    Lancet. 2023 Jan 25:S0140-6736(22)02469-2. doi: 10.1016/S0140-6736(22)02469.

  2. Wang Y, Li S, Pan Y, Li H, et al.
    Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial.
    Lancet. 2023 Feb 8:S0140-6736(22)02600-9. doi: 10.1016/S0140-6736(22)02600.

  3. Leichsenring F, Heim N, Leweke F, Spitzer C, et al.
    Borderline Personality Disorder: A Review.
    JAMA. 2023;329:670-679.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016